Characterisation of a cohort of opportunistically recruited patients with COVID-19 and approaches to patient stratification.

Saved in:
Bibliographic Details
Title: Characterisation of a cohort of opportunistically recruited patients with COVID-19 and approaches to patient stratification.
Authors: Shareef S; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Matthews E; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Dodds J; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Silverberg A; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Daly ME; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Ahmed W; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK., Bannard-Smith J; Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M13 9WL, UK., Gethings LA; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK.; School of Biosciences and Medicine, the University of Surrey, Guildford, Surrey, GU2 7XH, UK., King A; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK., Hughes C; Waters Corporation, Stamford Avenue, Altrincham Road, Wilmslow, Cheshire, SK9 4AX, UK., Fowler S; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK., Felton T; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK., Simpson A; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK.; Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, Greater Manchester, M23 9LT, UK., Mills ENC; Division of Immunology, Immunity to Infection and Respiratory Medicine, School of Biological Sciences, Manchester Institute of Biotechnology, Manchester Academic Health Sciences Centre, University of Manchester, Manchester, Greater Manchester, M1 7DN, UK. clare.mills@surrey.ac.uk.; School of Biosciences and Medicine, the University of Surrey, Guildford, Surrey, GU2 7XH, UK. clare.mills@surrey.ac.uk.
Source: BMC infectious diseases [BMC Infect Dis] 2026 Mar 31; Vol. 26 (1). Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2334
DOI:10.1186/s12879-026-13070-7